Company / EPS (Diluted)
Becton Dickinson EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$5.82
FY2025
5-year range
$3.94 / $5.88
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#26 of 159
Health Care
What the data says
Becton Dickinson's eps (diluted) of $5.82 is higher than 84% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $0.60 in FY2020 to $5.88 in FY2022.
Based on SEC 10-K filings.
5.82 in FY2025 with a 5-year CAGR of +57.5%. Top quartile in the Health Care sector.
Improved from $4.94 to $5.82 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- +57.5%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 159This company $5.82 Sector average $1.56
▼
+273.9% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 0.7% year-over-year.
- Ranks #26 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.82 | -0.7% |
| FY2024 | $5.86 | +18.6% |
| FY2023 | $4.94 | -16.0% |
| FY2022 | $5.88 | +49.2% |
| FY2021 | $3.94 | +556.7% |
| FY2020 | $0.60 | -84.8% |
| FY2019 | $3.94 | +556.7% |
| FY2018 | $0.60 | -87.0% |
| FY2017 | $4.60 | +2.4% |
| FY2016 | $4.49 | +34.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026